No Data
Pacific Biosciences of California Full Year 2024 Earnings: EPS Beats Expectations
PacBio Grants Equity Incentive Award to New Employee
UBS Downgrades Pacific Biosciences of California(PACB.US) to Hold Rating, Cuts Target Price to $1.5
SoftBank Adds to Shares in VTEX, YMM, Cuts NMRA and Exits DASH, Among Other Moves
Bernstein Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Cuts Target Price to $2
Pacific Biosciences of California Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Adjusted EPS Results. Also, Softbank Added 20.45M Shares in the Company.
NewToOptions : afternoon father, I've been researching PACB and wanting your opinion on if you would place $2 short period calls at this price?
TheFather OP NewToOptions : My plan on this one is to sell 25% of my shares when it reaches 2.25 in order to lower my total cost. That will leave me to wait all the way to 3.50 with the remainder of my shares. That is my opinion, and thank you for asking. I wish you the best this week.